women are two to three times more likely than men to develop gallstones, and the risk increases for everyone over the age of 40
The studys most important finding was the average 5.0 kg drop in body weight that was seen with semaglutide, mostly due to a reduction in body fat mass
If you are a suitable candidate, a personalized treatment plan will be created
In the STEP-1 trial, once-weekly semaglutide (a GLP-1 receptor agonist) produced a mean weight loss of 14.9% at 68 weeks
Because the range of what constitutes a normal menstrual cycle varies greatly among women, its important to compare any observed changes to ones standard periods
Still, with all the new weight loss medications appearing, it can be tricky to determine how these drugs stack up